As a result, the profound mechanism of therapy related inflammation attracted intensive attentions with the aims to better harness TLR, RLR, or cGAS mediated inflammatory responses in combination with the standard treatments to accelerate cancer regression and maximize patient response. This evidence concerns the gene CGAS and cancer.